Journal of Cell Science, Vol 108, Issue 4 1723-1733, Copyright © 1995 by Company of Biologists

JOURNAL ARTICLES

Regulation of growth and dissemination of a human lymphoma by CD44 splice variants

A Bartolazzi, D Jackson, K Bennett, A Aruffo, R Dickinson, J Shields, N Whittle and I Stamenkovic
Department of Pathology, Massachusetts General Hospital, Charlestown 02129, USA.

CD44 is a polymorphic cell surface glycoprotein, currently proposed to be the principal cell surface receptor for hyaluronan. However, different isoforms of CD44, expressed in human lymphoid tumor cells, appear to have distinct effects on the ability of the cells to attach to hyaluronan-coated surfaces and on their capacity to form tumors in vivo. In the present study, we address the mechanisms that may regulate CD44 isoform-dependent adhesion to hyaluronan. We use a human Burkitt lymphoma, stably transfected with six different alternatively spliced human CD44 isoforms, to determine their potential hyaluronan binding and tumor growth promoting roles. We show that transfectants expressing CD44 splice variants that contain variable exons 6-10, 7-10 and 8-10 adhere to hyaluronan-coated surfaces weakly and that corresponding tumor formation in vivo is delayed with respect to CD44-negative parental cell-derived tumors. Abundant shedding of these three isoforms may play a significant role in determining the rate of tumor development. Transfectants expressing variable exon 3, on the other hand, fail to display CD44-mediated adhesion to hyaluronan, but form bone marrow tumors rapidly following intravenous injection. These observations suggest that different mechanisms regulate CD44-mediated adhesion and tumor growth, and provide evidence that expression of exon v3 may confer novel ligand-binding properties.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. B. Wallach-Dayan, A. M. Rubinstein, C. Hand, R. Breuer, and D. Naor DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis Mol. Cancer Ther., June 1, 2008; 7(6): 1615 - 1623. [Abstract] [Full Text] [PDF]

				B. I. Hudson, A. M. Carter, E. Harja, A. Z. Kalea, M. Arriero, H. Yang, P. J. Grant, and A. M. Schmidt Identification, classification, and expression of RAGE gene splice variants FASEB J, May 1, 2008; 22(5): 1572 - 1580. [Abstract] [Full Text] [PDF]

				A Tzankov, A-C Pehrs, A Zimpfer, S Ascani, A Lugli, S Pileri, and S Dirnhofer Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases J. Clin. Pathol., October 1, 2003; 56(10): 747 - 752. [Abstract] [Full Text] [PDF]

				J. Cichy, R. Bals, J. Potempa, A. Mani, and E. Pure Proteinase-mediated Release of Epithelial Cell-associated CD44. EXTRACELLULAR CD44 COMPLEXES WITH COMPONENTS OF CELLULAR MATRICES J. Biol. Chem., November 8, 2002; 277(46): 44440 - 44447. [Abstract] [Full Text] [PDF]

				W.-H. Yu, J. F. Woessner Jr., J. D. McNeish, and I. Stamenkovic CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling Genes & Dev., February 1, 2002; 16(3): 307 - 323. [Abstract] [Full Text] [PDF]

				M. Kajita, Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinoh, and M. Seiki Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration J. Cell Biol., May 28, 2001; 153(5): 893 - 904. [Abstract] [Full Text] [PDF]

				S. B. Wallach-Dayan, V. Grabovsky, J. Moll, J. Sleeman, P. Herrlich, R. Alon, and D. Naor CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes J. Cell Sci., January 10, 2001; 114(19): 3463 - 3477. [Abstract] [Full Text] [PDF]

				P. Drillenburg and S. T. Pals Cell adhesion receptors in lymphoma dissemination Blood, March 15, 2000; 95(6): 1900 - 1910. [Abstract] [Full Text] [PDF]

				M. P. Martegani, F. Del Prete, A. Gasbarri, P. G. Natali, and A. Bartolazzi Structural Variability of CD44v Molecules and Reliability of Immunodetection of CD44 Isoforms Using mAbs Specific for CD44 Variant Exon Products Am. J. Pathol., January 1, 1999; 154(1): 291 - 300. [Abstract] [Full Text] [PDF]

				M. V. Bell, A. E. Cowper, M.-P. Lefranc, J. I. Bell, and G. R. Screaton Influence of Intron Length on Alternative Splicing of CD44 Mol. Cell. Biol., October 1, 1998; 18(10): 5930 - 5941. [Abstract] [Full Text]

				Y. Yakushijin, J. Steckel, S. Kharbanda, R. Hasserjian, D. Neuberg, W.-m. Jiang, I. Anderson, and M. A. Shipp A Directly Spliced Exon 10-Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma Blood, June 1, 1998; 91(11): 4282 - 4291. [Abstract] [Full Text] [PDF]

				C. Boshoff, S.-J. Gao, L. E. Healy, S. Matthews, A. J. Thomas, L. Coignet, R. A. Warnke, J. A. Strauchen, E. Matutes, O. W. Kamel, et al. Establishing a KSHV+ Cell Line (BCP-1) From Peripheral Blood and Characterizing Its Growth in Nod/SCID Mice Blood, March 1, 1998; 91(5): 1671 - 1679. [Abstract] [Full Text] [PDF]

				T. P. Skelton, C. Zeng, A. Nocks, and I. Stamenkovic Glycosylation Provides Both Stimulatory and Inhibitory Effects on Cell Surface and Soluble CD44 Binding to Hyaluronan J. Cell Biol., January 26, 1998; 140(2): 431 - 446. [Abstract] [Full Text] [PDF]

				Q. Yu, B. P. Toole, and I. Stamenkovic Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function J. Exp. Med., December 15, 1997; 186(12): 1985 - 1996. [Abstract] [Full Text] [PDF]

				K. Takahashi, I. Stamenkovic, M. Cutler, A. Dasgupta, and K. K. Tanabe Keratan Sulfate Modification of CD44 Modulates Adhesion to Hyaluronate J. Biol. Chem., April 19, 1996; 271(16): 9490 - 9496. [Abstract] [Full Text] [PDF]